Medicare Enrolled

Dr. Sridhar Allam, M.D., M.P.H.

Nephrology · Mcallen, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1100 E DOVE AVE STE 200, Mcallen, TX 78504
9563628030
Registered in NPPES since 2008
NPI: 1700061819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Allam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Allam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Allam

Dr. Sridhar Allam is a nephrology specialist in Mcallen, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Allam performed 2,434 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Allam received a total of $331,825 from 35 pharmaceutical and/or device companies across 476 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Allam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 19% volume in TX $331,825 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,434
Medicare services
Top 19% in TX for nephrology
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
904 $60 $247
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
560 $100 $350
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
189 $54 $193
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
171 $72 $306
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
167 $87 $283
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
139 $98 $380
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
124 $53 $258
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
102 $84 $400
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
49 $127 $404
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
18 $30 $75
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
11 $27 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$331,825
Total received (2018-2024)
Avg $47,404/year across 7 years
Top 1% in TX for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
476
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$113,289
2023
$97,948
2022
$53,761
2021
$20,335
2020
$29,998
2019
$16,230
2018
$264

Payments by company (2024)

CALLIDITAS THERAPEUTICS US INC.
$45,024
Takeda Pharmaceuticals U.S.A., Inc.
$40,764
SANOFI-AVENTIS U.S. LLC
$13,711
Alexion Pharmaceuticals, Inc.
$13,021
Travere Therapeutics, Inc.
$249
Amgen Inc.
$219
Gilead Sciences, Inc.
$121
Paratek Pharmaceuticals, Inc.
$48
Veloxis Pharmaceuticals, Inc.
$39
AstraZeneca Pharmaceuticals LP
$35
AKEBIA THERAPEUTICS INC
$25
Novartis Pharmaceuticals Corporation
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$105,286
Alexion Pharmaceuticals, Inc.
$72,970
Veloxis Pharmaceuticals, Inc.
$52,805
CALLIDITAS THERAPEUTICS US INC.
$45,024
SANOFI-AVENTIS U.S. LLC
$34,592
Amicus Therapeutics, Inc.
$6,677
Calliditas Therapeutics US Inc.
$6,515
GENZYME CORPORATION
$3,200
Mallinckrodt Enterprises LLC
$2,652
Travere Therapeutics, Inc.
$277
Amgen Inc.
$241
AstraZeneca Pharmaceuticals LP
$175
Horizon Therapeutics plc
$163
Astellas Pharma US Inc
$156
Bayer HealthCare Pharmaceuticals Inc.
$151
E.R. Squibb & Sons, L.L.C.
$130
Gilead Sciences, Inc.
$121
Keryx Biopharmaceuticals, Inc.
$121
AbbVie Inc.
$115
Vifor Pharma, Inc.
$78
Paratek Pharmaceuticals, Inc.
$48
GlaxoSmithKline, LLC.
$39
OPKO Pharmaceuticals, LLC
$36
Novo Nordisk Inc
$33
Bard Peripheral Vascular, Inc.
$32
AKEBIA THERAPEUTICS INC
$25
Boston Scientific Corporation
$24
Pharmacosmos Therapeutics Inc.
$23
Novartis Pharmaceuticals Corporation
$19
Osprey Medical Inc
$19
Abbott Laboratories
$18
Otsuka America Pharmaceutical, Inc.
$17
Ultragenyx Pharmaceutical Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Chiesi USA, Inc.
$13
Top 3 companies account for 69.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Auryxia · BENLYSTA · CLEVIPREX · CRESEMBA · CROSSER · Cryvista · DyeVert · ENVARSUS · Envarsus · Envarsus XR (SP) · FARXIGA · FREESTYLE LIBRE · GALAFOLD · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIVTENCITY · Livdelzi · MAVYRET · MONOFERRIC · NULOJIX · NUZYRA · RAYALDEE · RAYOS · RYBELSUS · Rybelsus · SOLIRIS · TARPEYO · TAVNEOS · THYMOGLOBULIN · ULTOMIRIS · Ultomiris · Vafseo · Varithena Administration Pack · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nephrology specialist in Mcallen?
Compare nephrologists in the Mcallen area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists in nearby ZIP areas
24
County median income
$52,281
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS HEALTH SYSTEM
3.4 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Allam is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Allam experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Allam performed 904 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Allam receive payments from pharmaceutical companies?
Yes. Dr. Allam received a total of $331,825 from 35 companies across 476 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Allam's costs compare to other nephrologists in Mcallen?
Dr. Allam's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Allam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →